NovartisNOVN 
$97.381.11%24h
1.11%24h
Global rank62
Market cap$200.16B
Change 7d1.88%
YTD Performance1.34%
SP500 benchmarkUnderperform
P/E0
P/S4.29
Revenue$46.66B
Earnings$14.85B
Dividend yield3.6%
Main Sector
Healthcare
Novartis (NOVN) Cash on Hand
NOVN Cash on Hand in 2022: $13.96B
According to Novartis latest financial reports the cash on hand of NOVN is $13.96B, an decrease of -25.00% to 2022. At the end of 2022 company had $18.61B cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
NOVN Cash on Hand History from 2018 to 2023
-
Value:-
NOVN Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $13.96B | -25.00% |
| 2022 | $18.61B | -33.79% |
| 2021 | $28.11B | 148.94% |
| 2020 | $11.29B | -1.34% |
| 2019 | $11.45B | -28.30% |
| 2018 | $15.96B | - |
View the Top Cash on Hand Companies 
